Patent · US Expired

Ghrelin binding nucleic acids

US7750140B2 · kind B2 · utility

6Cited by

2References

18Claims

0Family size

Assignee

NOXXON Pharma AG · DE

Inventors

Steffen Helmling · Boston, US
Dirk Eulberg · Berlin, DE
Christian Maasch · Berlin, DE
Sven Klussmann · Berlin, DE

Key dates

Filing date	Aug 1, 2003
Grant date	Jul 6, 2010
Priority date	—
Expiry date	Oct 6, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is related to an antagonist of ghrelin, wherein the antagonist is a nucleic acid, and whereby preferably the nucleic acid is binding to ghrelin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.